Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Web Exclusives
Managing Anxiety in Patients with Advanced Cancer
By
Meg Barbor, MPH
Web Exclusives
,
Symptom Management
Read More ›
Practice-Changing Results: Adding Immunotherapy to Chemotherapy Extends Survival in Metastatic Triple-Negative Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
Oral Toxicities Associated with Cancer Therapies: What’s Old Is New Again
By
Meg Barbor, MPH
Web Exclusives
Read More ›
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
By
Phoebe Starr
Emerging Therapies
,
Web Exclusives
Read More ›
Two New Therapies Active in NSCLC with EGFR/HER2 Exon 20 Mutations
By
Phoebe Starr
Web Exclusives
,
Emerging Therapies
Read More ›
Cognitive Behavioral Therapy More Effective Than Acupuncture for Mild Insomnia in Cancer Survivors
Web Exclusives
Read More ›
Less Is More: 6 Months of Trastuzumab Treatment Equivalent to 12 Months in HER2-Positive Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer
Breast Cancer
,
Web Exclusives
Read More ›
Chemotherapy Can Be Spared in Many Patients with Early Breast Cancer: Devil Is In the Details
Breast Cancer
,
Web Exclusives
Read More ›
Timing of Palliative Care Consults Affects Healthcare Utilization in Elderly Patients with Pancreatic Cancer
Pancreatic Cancer
,
Web Exclusives
Read More ›
Page 4 of 7
1
2
3
4
5
6
7